Gyre Therapeutics, Inc. Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Gyre Therapeutics, Inc. (GYRE) had Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment of $12.70 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment · last filed 2026-08-07
- 2026-06-30: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $12.70M.
- 2026-03-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $8.17M.
- 2025-12-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $11.00M; Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment as first filed $7.58M.
- 2025-09-30: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment $6.93M.
| Period end | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment as first filed |
|---|---|---|
| 2026-06-30 | $12.70M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $8.17M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $11.00M 10-Q · filed 2026-08-07 | $7.58M 10-K · filed 2026-03-13 |
| 2025-09-30 | $6.93M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $6.42M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $6.08M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $5.60M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $5.32M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $4.80M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $4.67M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $4.26M 10-K · filed 2025-03-17 | |
| 2022-12-31 | $4.00M 10-K · filed 2024-03-27 | |
| 2019-12-31 | $400.00K 10-K · filed 2020-02-20 | |
| 2018-12-31 | $300.00K 10-K · filed 2020-02-20 | $285.00K 10-K · filed 2019-03-08 |
| 2017-12-31 | $2.02M 10-K · filed 2019-03-08 | |
| 2016-12-31 | $1.86M 10-K · filed 2018-03-19 | |
| 2015-12-31 | $5.70M 10-K · filed 2017-03-08 | |
| 2014-12-31 | $6.65M 10-K · filed 2016-03-09 | $1.67M 10-K · filed 2015-03-16 |
| 2013-12-31 | $6.87M 8-K/A · filed 2015-10-23 | $1.88M 10-K · filed 2014-03-14 |
| 2012-12-31 | $3.87M 10-K · filed 2014-03-14 | |
| 2011-12-31 | $12.83M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |